Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS
Open Access
- 8 February 2023
- journal article
- letter
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (13) , 2952-2956
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaNew England Journal of Medicine, 2016
- Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevanceBlood, 2016
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaNature, 2014
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database MergeJournal of Clinical Oncology, 2012
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemiaMolecular Carcinogenesis, 2003
- THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIESBritish Journal of Haematology, 1997
- Mutations of the P53 gene in acute myeloid leukaemiaBritish Journal of Haematology, 1992